1.8300
01-November-24 10:56:12
15 minutes delayed
Stocks
+0.0200
+1.10%
Today's range
1.8300 - 1.8440
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 09:00:00 By Nasdaq GlobeNewswire